Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.58 - $17.36 $1.3 Million - $1.66 Million
-95,506 Reduced 23.41%
312,426 $4.91 Million
Q4 2023

Feb 14, 2024

BUY
$10.11 - $16.54 $3.82 Million - $6.26 Million
378,226 Added 1273.23%
407,932 $6.58 Million
Q3 2023

Nov 14, 2023

SELL
$12.46 - $15.48 $872,200 - $1.08 Million
-70,000 Reduced 70.21%
29,706 $377,000
Q2 2023

Aug 14, 2023

SELL
$13.28 - $15.96 $1.05 Million - $1.26 Million
-79,000 Reduced 44.21%
99,706 $1.4 Million
Q1 2023

May 15, 2023

SELL
$14.26 - $22.1 $2.56 Million - $3.97 Million
-179,847 Reduced 50.16%
178,706 $2.76 Million
Q4 2022

Feb 14, 2023

BUY
$14.85 - $19.04 $740,317 - $949,201
49,853 Added 16.15%
358,553 $5.88 Million
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $1.88 Million - $3.07 Million
151,631 Added 96.54%
308,700 $5.71 Million
Q2 2022

Aug 15, 2022

BUY
$9.11 - $13.98 $1.43 Million - $2.2 Million
157,069 New
157,069 $2.07 Million
Q1 2022

May 16, 2022

SELL
$6.87 - $11.11 $1.05 Million - $1.7 Million
-152,649 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $1.18 Million - $5.67 Million
152,649 New
152,649 $1.49 Million
Q3 2020

Nov 16, 2020

SELL
$43.8 - $58.16 $4.29 Million - $5.69 Million
-97,854 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$37.05 - $65.03 $770,677 - $1.35 Million
-20,801 Reduced 17.53%
97,854 $5.84 Million
Q1 2020

May 15, 2020

BUY
$33.63 - $69.4 $2.31 Million - $4.77 Million
68,760 Added 137.81%
118,655 $4.89 Million
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $281,305 - $620,558
8,874 Added 21.63%
49,895 $3.11 Million
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $818,368 - $1.59 Million
41,021 New
41,021 $1.39 Million
Q3 2018

Nov 14, 2018

SELL
$33.57 - $42.1 $399,483 - $500,990
-11,900 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$20.06 - $44.95 $238,713 - $534,905
11,900 New
11,900 $468,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.